The ‘molecular mail’ sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a new study.
The ‘molecular mail’ sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a new study.